DEF 14A

Company

Immuneering Corp

Filed

April 23, 2024

Period of Report

April 23, 2024

Accession Number

0001790340-24-000044

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →